Clinical Trial Update: Impact of Ticagrelor Re-load on Pharmacodynamic Profiles [NA]

View source ↗

Summary

The update examines whether a ticagrelor re-load dose alters pharmacodynamic measures in patients with coronary artery disease. The results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2015-06-10